Lithium Australia involved in IPO of LiGeneration
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Lithium Australia (ASX:LIT) has announced a Canadian alliance with LiGeneration Limited.
Seed capital has been provided by LIT to LiGeneration which is planning to list on the Australian stock exchange through an IPO by the end of the year.
Shareholders in LIT will be given priority entitlement to IPO share subscriptions in the LiGeneration float.
LIT will be a significant shareholder in LiGeneration and will provide both technical and administrative support.
LiGeneration’s assets include lithium pegmatites located in Quebec, Canada. Of which the IPO hopeful owns a 100% interest of the Whabouchi Southwest and Southeast lithium projects.
The more than 14,000ha area covered in three separate projects neighbours the world-class Nemaska Lithium Whabouchi Mine with is the second largest and richest global lithium reserve.
LiGeneration also holds a 100% stake in the Wells-Lacourciere lithium project. Historical exploration at the site consisting of trenching and bulk sampling returned assay results between 2.87% Li2O and 4.0% Li2O.
There is no guarantee the IPO of LiGeneration will add market value to LIT and its shareholders, so seek professional financial advice if considering LIT for your portfolio.
Further to the announcement surrounding LiGeneration, LIT has lodged a provisional application for an Australian patent with corresponding trademarks in relation to a caustic digestion process which has been entitled LieNA.
LIT has also confirmed that it has received funds to fully pay up the remaining two holdings in the LITCD series. Upon clearance of the funds and corresponding shares have been issued, Lit will make an application to the ASX for the current series of unlisted partly paid shares to become listed. To which an Appendix 3B will be issued in due course.
LIT presented this week at the Diggers and Dealers forum in Kalgoorlie, Western Australia.
The full presentation can be found here.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.